Skip to main content
logo
Chimeric Therapeutics Limited (ASX:CHM)
Australia flag Australia · Delayed Price · Currency is AUD
0.0050
+0.0010 (25.00%)
Sep 25, 2026, 4:10 PM AEST

Chimeric Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
-0.19-0.1912.687.464.512.62
Revenue Growth
--70.09%65.52%72.16%-
Gross Profit
-0.19-0.1911.847.464.512.62
Operating Income
-8.55-8.55-6.49-12.31-24.98-14.57
Net Income
-18.81-18.81-10.43-12.53-25.92-15.9
Earnings Per Share
-0.61-0.61-0.77-1.80-5.98-4.42
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
0.80.85.763.052.3618.38
Total Debt
0.660.66----
Net Cash (Debt)
0.140.145.763.052.3618.38
Net Cash Growth
-94.45%-97.59%88.58%29.22%-87.15%-17.98%
Net Cash Per Share
0.000.000.430.440.555.11

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-10.78-10.78-7.28-7.54-16.31-13.15
Capital Expenditures
------0.01
Free Cash Flow
-10.78-10.78-7.28-7.54-16.31-13.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
--93.32%100.00%100.00%100.00%
Operating Margin
---51.14%-165.01%-554.44%-556.82%
Pretax Margin
9896.16%9896.16%-81.36%-167.88%-573.14%-601.22%
Profit Margin
---82.23%-168.01%-575.20%-607.48%
FCF Margin
---57.36%-101.07%-361.89%-503.04%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
-3.11-18.740.642.354.2714.95